Manejo de la coinfección por virus de la hepatitis B y VIH en el Perú

Vivian Levy; Robert M. Grant; César Cabezas

doi:10.17843/rpmesp.2007.244.1140

Authors

Vivian Levy Gladstone Institute of Virology and Immunology, University of California. San Francisco, USA. Médico infectólogo.
Robert M. Grant Gladstone Institute of Virology and Immunology, University of California. San Francisco, USA. Médico infectólogo.
César Cabezas Instituto Nacional de Salud. Lima, Perú. Instituto de Medicina Tropical “Daniel A. Carrión. Universidad Nacional Mayor de San Marcos. Lima, Perú. Médico infectólogo

DOI:

https://doi.org/10.17843/rpmesp.2007.244.1140

Keywords:

Hepatitis B/ therapy, HIV/AIDS / therapy, Perú

Abstract

In Peru, men who have sex with men (MSM) should be added to the groups at risk for hepatitis B (HBV) infection which include persons from endemic areas, health care workers and commercial sex workers. Given the shared sexual risk factors for transmission, co-infection with HBV and HIV is common in MSM and high risk heterosexuals. The treatment of chronic HBV infection needs to be carefully coordinated with HIV management in HBV-HIV co-infected patients. The main treatment goals for HBV infection are to suppress HBV replication, improve liver function, and minimize the emergence of HBV and HIV drug resistance. In this article, we review the epidemiology of HBV in Peru, the natural history of HBV-HIV co-infection, and describe current treatment options in the Peruvian context.